q&a

Latest Posts

OS Therapies (NYSE: OSTX) is a most cancers immunotherapy firm engaged within the improvement...

Market

OS Therapies is actively advancing its osteosarcoma immunotherapy: CEO Paul Romness | AlphaStreet

Depth Therapeutics, Inc. (NASDAQ: INTS) is a medical biotechnology firm engaged within the discovery...

Market

Depth Therapeutics is establishing a brand new discipline of localized most cancers discount: CEO | AlphaStreet

Envoy Medical (NASDAQ: COCH) is a frontrunner in progressive listening to options, providing merchandise...

Market

Envoy Medical is well-positioned to achieve market share in listening to implant area: CEO | AlphaStreet